Physician profile
Cameron Etebari
NPI 1043950058
$2,670.12
in general payments reported to CMS, 2019-2025
8 companies · $1,828 in 2025
The $1,828 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $143 · 2024: $699 · 2025: $1,828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,784 · Travel and Lodging: $886.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,784.22 |
| Travel and Lodging | $885.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,167.00 | 2025 | Na, Smartlock |
| Mentor Worldwide LLC | $485.88 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Polynovo North America LLC | $339.10 | 2024-2025 | Novosorb Btm |
| Abbvie INC. | $233.91 | 2024-2025 | |
| Mesh Suture INC | $194.01 | 2024 | |
| Innovation Technologies INC | $117.92 | 2023 | Irrisept |
| Vertex Pharmaceuticals Incorporated | $107.24 | 2025 | |
| Vericel Corporation | $25.06 | 2023 | Epicel (Cultured Epidermal Autografts) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Etebari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.